|Mr. Sebastien G. St-Louis||Co-Founder, Pres, CEO & Director||358k||N/A||1984|
|Mr. Ed Chaplin||Exec. Officer||278.7k||N/A||1970|
|Mr. Adam Miron||Co-Founder & Director||309.58k||N/A||1984|
|Mr. James McMillan||VP of Bus. Devel.||325.58k||N/A||1968|
|Dr. Terence Lake DVM||Vice-Pres of Corp. & Social Responsibility||256.15k||N/A||N/A|
HEXO Corp., through its subsidiary, HEXO Operations Inc., produces, markets, and sells cannabis in Canada. The company offers dried cannabis under the Time of Day and H2 lines; Elixir, a cannabis oil sublingual mist product line; and Decarb, an activated fine-milled cannabis powder product. It provides its products under the HEXO and Hydropothecary brand names. The company serves medical and adult-use markets. The company was formerly known as The Hydropothecary Corporation and changed its name to HEXO Corp. in August 2018. HEXO Corp. is headquartered in Gatineau, Canada.
HEXO Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.